dr. sweeney on chemotherapy versus abiraterone for mcrpc
Published 6 years ago • 297 plays • Length 1:55Download video MP4
Download video MP3
Similar videos
-
1:09
dr. sweeney on chemotherapy in prostate cancer
-
1:19
comparing abiraterone and docetaxel in prostate cancer treatment
-
7:58
abiraterone and chemotherapy in crpc
-
1:27
dr. mark scholz on using abiraterone in mcrpc
-
1:20
dr. sweeney on evolving role of chemotherapy for hormone-sensitive prostate cancer
-
0:54
convincing long-term survival with abiraterone in mcrpc
-
1:18
dr. sweeney on the future of prostate cancer research
-
2:31
dr. tagawa on abiraterone and docetaxel in mcrpc
-
1:40
dr. maughan discusses abiraterone plus olaparib in mcrpc
-
2:32
dr. sweeney on the optimal use of cabazitaxel
-
1:45
dr. sweeney discusses tailoring treatment in prostate cancer
-
2:46
dr. sweeney on the phase iii enzamet trial in metastatic hormone-sensitive prostate cancer
-
3:16
counseling patients with mcrpc
-
4:25
chemotherapy versus abiraterone acetate in mhspca
-
0:45
dr. hahn on patients with prostate cancer whom neither docetaxel or abiraterone is an option
-
1:26
dr. oh discusses choosing abiraterone in prostate cancer
-
1:05
dr. agarwal on candidates for docetaxel versus abiraterone and prednisone
-
1:10
dr. daniel petrylak discusses chemotherapy in prostate cancer
-
1:22
dr. bryce on the use of abiraterone versus docetaxel in patients with prostate cancer